Atossa Genetics Inc (ATOS)

Atossa Genetics Inc (ATOS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $24.3M; returns 1 day -4.4%, 1 week -10.7%, 1 year -81.1%.

Atossa Therapeutics, Inc. (ATOS), based in Seattle, Washington, is a clinical-stage biopharmaceutical company focused on developing therapeutics and diagnostic products for breast cancer and other breast-related conditions.

Groups ATOS belongs to

• Recent Reverse Splits
• Breast Cancer Treatment
• Oncology
• Women's Health
• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Healthcare
• Life Sciences
• Clinical Stage
• Preventive Care
• Minimally Invasive Surgery
• Unmet Medical Needs

ATOS financial model: income statement, cash flow and balance sheet